Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Regulation of Bone Formation in Renal Osteodystrophy
NCT00560300Phase 2Completed
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- Nov 2000
- Modality
- Polymer-based Nanoparticles, Orthosteric Ligands
01
Overview
A Phase 2 trial of doxercalciferol, calcitriol, sevelamer carbonate, calcium carbonate in secondary hyperparathyroidism (SHPT), renal osteodystrophy, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Started Nov 2000; status: completed.
02
Drugs
doxercalciferolcalcitriolsevelamer carbonatecalcium carbonate
03
Conditions
secondary hyperparathyroidism (SHPT)renal osteodystrophy
Beyond the preview
Go deeper on NCT00560300.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00560300.